![Mark Chadwick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de Mark Chadwick
Antiguos cargos conocidos de Mark Chadwick.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
![]() Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Consejero General | 23/06/2010 | 11/03/2013 |
J.A. Kemp LLP
![]() J.A. Kemp LLP Miscellaneous Commercial ServicesCommercial Services J.A. Kemp & Co. provides protection for patents, trade marks and intellectual property, under International, European and UK law. The company also provides legal advice in the areas of biotechnology, chemistry, electronics and engineering, patent assignments and trade marks. It has offices in the United Kingdom and Germany. The company is headquartered in London, UK. | Consejero General | - | - |
Formación de Mark Chadwick.
University of Cambridge | Undergraduate Degree |
University of East Anglia | Doctorate Degree |
Estadísticas
Internacional
Reino Unido | 4 |
Países Bajos | 2 |
Operativa
General Counsel | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorial
Consumer Services | 3 |
Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
J.A. Kemp LLP
![]() J.A. Kemp LLP Miscellaneous Commercial ServicesCommercial Services J.A. Kemp & Co. provides protection for patents, trade marks and intellectual property, under International, European and UK law. The company also provides legal advice in the areas of biotechnology, chemistry, electronics and engineering, patent assignments and trade marks. It has offices in the United Kingdom and Germany. The company is headquartered in London, UK. | Commercial Services |
Amsterdam Molecular Therapeutics (AMT) Holding NV
![]() Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
- Bolsa de valores
- Insiders
- Mark Chadwick
- Experiencia